Importantly, bi-steric mTORi such as RMC-4627, have shown potent and selective inhibition of 4E-BP1 phosphorylation leading to tumor regression in B-cell acute lymphoblastic leukemia xenografts [327] and breast cancer xenografts [325, 326]. Here, EIF4EBP1 is linked to neoplasm.